Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions

Turner, Daniel; Basdekis-Jozsa, Raphaela; Dekker, Arne; Briken, Peer

doi:10.3109/15622975.2013.839052

Cited by 16 publications

(10 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The WFSBP guidelines indicate the use of LA corresponds with Level 5 (the second highest level of the algorithm) or higher, suggesting that LA be used in the treatment of adult males with a high risk of sexual violence, severe paraphilias, and sexually sadistic fantasies and/or behavior or physical violence (Thibault et al, 2010). Turner, Basdekis-Jozsa, Dekker, and Briken (2014) investigated the factors influencing clinician’s decisions to place an offender on testosterone-lowering medications. These authors found that clinicians’ attitudes toward the importance of certain characteristics, specific to the individual offender, were in line with the WFSBP guidelines, particularly previous treatment failure and inappropriate behavior under supervision (Turner et al, 2014).…”

Section: La As An Adjunct To Psychotherapymentioning

confidence: 99%

“…Turner, Basdekis-Jozsa, Dekker, and Briken (2014) investigated the factors influencing clinician’s decisions to place an offender on testosterone-lowering medications. These authors found that clinicians’ attitudes toward the importance of certain characteristics, specific to the individual offender, were in line with the WFSBP guidelines, particularly previous treatment failure and inappropriate behavior under supervision (Turner et al, 2014).…”

Section: La As An Adjunct To Psychotherapymentioning

confidence: 99%

See 1 more Smart Citation

The Use of Leuprolide Acetate in the Management of High-Risk Sex Offenders

et al. 2018

View full text Add to dashboard Cite

The present study investigates whether leuprolide acetate (Lupron) adds to the efficacy of traditional sex offender treatment. A group of sex offenders receiving both Lupron and cognitive behavioral therapy (CBT; n = 25) were compared with a group of sex offenders receiving only CBT ( n = 22). Treated subjects were compared with norms available with reference to the Static-99R, as well as compared with a sample of untreated, nonsexual violent offenders ( n = 81), to provide baseline data regarding risk of violent recidivism. Results indicated that subjects receiving Lupron were at significantly higher risk of recidivism and significantly more likely to be diagnosed with a paraphilia than subjects receiving only CBT, a priori. Both treated groups of sexual offenders recidivated at substantially lower rates than predicted by the Static-99R. Currently, this study represents the only, long-term outcome study on Lupron administration using officially recorded recidivism as the primary dependent measure.

show abstract

Section: La As An Adjunct To Psychotherapymentioning

confidence: 99%

Section: La As An Adjunct To Psychotherapymentioning

confidence: 99%

The Use of Leuprolide Acetate in the Management of High-Risk Sex Offenders

et al. 2018

View full text Add to dashboard Cite

show abstract

“…The efficacy of GnRH analogs in reducing paraphilic urges has been reported (Eher, ; Lewis et al, ; Thibaut, Barra, Gordon, Cosyns, Bradford, & WFSBP Task Force on Sexual Disorders, ; Turner & Briken, ). Clinicians sometimes use testosterone‐lowering medications when the patient has a “history of sexual offender treatment failure” (Turner, Basdekis‐Jozsa, Dekker, & Briken, ).…”

Section: Treatment Studiesmentioning

confidence: 99%

A narrative review of research on clinical responses to the problem of sexual offenses in the last decade

Fedoroff

Briken

2020

Behavioral Sci & The Law

Self Cite

View full text Add to dashboard Cite

Research on the treatment and programs for people who have committed sexual offenses has greatly increased in the past decade. The aim of this review is to discuss research that has been published over that period (2010–2019) that is relevant for treatment providers. The articles included in this review were found through PsycINFO and PubMed (Medline) using the keywords “treatment or therapy” and “sex offen*”. The inclusion criteria were publications that discuss treatment of persons who have committed sexual offenses (written in the English language only). Any articles that examined only special populations were excluded, such as those that examined persons who committed sexual offenses who were female, had intellectual disabilities, deafness, juveniles, etc., because these groups will likely have needs and responsivity factors that differ from the “average” natal‐born male sex offender. Results showed that several meta‐analyses indicate that treatment is effective in reducing sexual recidivism. The most frequently used treatment for sex offenders is cognitive behavioral therapy, which is often provided in conjunction with pharmacological treatment to reduce sexual impulsivity and/or sex drive. This review is limited to the specific key search terms. The findings of this review support the use of treatment and a community reintegration approach when treating persons who have committed sexual crimes to prevent sexual recidivism.

show abstract

“…In a recent study by Koo et al, the reason for suboptimal response rates has been attributed to the unexpected sudden increased hypersexual impulses associated with transient upsurges of serum T, immediately following treatment (21,22). Nevertheless, ADT is usually associated with a variety of side-effects, ranging from weight gain, hot flushes, and muscle weakness to more severe side-effects such as gynecomastia, an increased incidence of thromboembolism and decreased bone mineral density, even osteoporosis (28,29). The effects of chemical castration are reversible after cessation of treatment.…”

Section: Gnrh Analogs (Or Agonists)mentioning

confidence: 99%